Healthcare robotics has reached a mainstream inflection point, driven by an aging global population, a shortage of skilled surgeons and clinical staff, and demand for minimally invasive procedures. Broad robotics ETFs have expanded their allocations to med-tech innovators like Intuitive Surgical ISRG. Intuitive Surgical reported da Vinci procedures rose approximately 16% year over year in the first quarter of 2026, with its installed base growing to 11,395 systems as of March 31, 2026, reflecting an increase of 12%. The da Vinci 5 platform is driving higher utilization, and its data-rich ecosystem is creating a long-term competitive advantage in AI. Illumina ILMN exemplifies robotics in lab automation with systems like the Infinium Automated Pipetting System and Digital Microfluidics, which minimize human error and reduce processing time for large-scale genomic studies and clinical diagnostics. Stryker SYK leads in orthopedic robotics with its Mako system for robotic-arm assisted total knee, partial knee, and total hip replacements.